Teams link: Join the Meeting Now

Meeting ID: 234 297 242 669 890

Passcode: EG2uo7X8

Learning Objectives: 

  • Describe the pathophysiology of transthyretin cardiac amyloidosis (ATTR-CM)

  • Evaluate primary literature behind the disease-modifying therapies and describe their mechanisms of action

  • Assess the role and tolerability of heart failure guideline directed medical therapy (HF GDMT) in ATTR-CM

Session date: 
10/22/2026 - 2:00pm to 3:00pm CDT
Location: 
In-person and Virtually
Will be determined by room availability
600 Highland Ave
Madison, WI 53705
United States
See map: Google Maps
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Anna Vardaro, PharmD